CKD G3bに対するスピロノラクトン
長澤将
00:00 | 00:00
BARACK-D
Hobbs, F.D.R., McManus, R.J., Taylor, C.J. et al. Low-dose spironolactone and cardiovascular outcomes in moderate stage chronic kidney disease: a randomized controlled trial. Nat Med (2024). https://doi.org/10.1038/s41591-024-03263-5
Hobbs, F.D.R., McManus, R.J., Taylor, C.J. et al. Low-dose spironolactone and cardiovascular outcomes in moderate stage chronic kidney disease: a randomized controlled trial. Nat Med (2024). https://doi.org/10.1038/s41591-024-03263-5
この記事が気に入ったらサポートをしてみませんか？